1. Analgesic and Anti-Inflammatory Effects of 1% Topical Cannabidiol Gel in Animal Models.
- Author
-
Bunman S, Muengtaweepongsa S, Piyayotai D, Charlermroj R, Kanjana K, Kaew-Amdee S, Makornwattana M, and Kim S
- Subjects
- Animals, Mice, Male, Inflammation drug therapy, Carrageenan, Diclofenac administration & dosage, Diclofenac pharmacology, Pain drug therapy, Cannabidiol pharmacology, Cannabidiol administration & dosage, Anti-Inflammatory Agents pharmacology, Anti-Inflammatory Agents administration & dosage, Edema drug therapy, Edema chemically induced, Analgesics pharmacology, Analgesics administration & dosage, Administration, Topical, Disease Models, Animal, Gels
- Abstract
Introduction: Cannabidiol (CBD), a phytocannabinoid isolated from cannabis plants, is an interesting candidate for studying its anti-inflammatory effects, especially in the pre-clinical and animal models. Its anti-inflammatory effects, such as reduction of edema and arthritis, have been demonstrated in animal models. However, topical CBD administration requires further evaluation of CBD dosage and efficacy in animal models and clinical settings. Methods: This in vivo study investigated the anti-inflammatory effects of topical CBD administration in an animal model. Scientific experiments, including the formalin test, writhing test, carrageenan-induced edema, histopathological examination, and detection of various proinflammatory mediators, were performed. Results: The anti-inflammatory effects in vivo after inflammation induction, represented by decreased times of paw licking, degree of paw edema, and decreased writhing response, showed that 1% of tropical CBD use had significantly comparable or better anti-inflammatory effects when compared with tropical diclofenac, an anti-inflammatory agent. Moreover, the anti-inflammatory effects were significant compared with the placebo. In addition, the histopathological examination showed that topical CBD drastically reduced leukocyte infiltration and the degree of inflammation. This study also showed that the levels of various proinflammatory mediators in the plasma of mice treated with topical CBD did not differ from those treated with diclofenac. Conclusions: The topical administration of 1% CBD gel is a potentially effective candidate for an anti-inflammatory agent. Candidate for an anti-inflammatory agent.
- Published
- 2024
- Full Text
- View/download PDF